Skip to main content
Erschienen in: Rheumatology International 6/2010

01.04.2010 | Original Article

Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1

verfasst von: Ana Karina Ferraz-Chaoui, Ajax Mercês Atta, Maria Luiza Sousa Atta, Bernardo Galvão-Castro, Mittermayer B. Santiago

Erschienen in: Rheumatology International | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Human T cell lymphotropic virus type 1 (HTLV-1) is endemic in many regions of the world, including Brazil, and has been associated to several immunological manifestations such as arthritis, uveitis, dermatitis and Sjögren’s syndrome. This study was intended to evaluate the frequency of autoantibodies in patients infected with HTLV-1 and manifesting keratoconjunctivitis sicca (KCS). HTLV-1 patients with KCS, enrolled in a reference ambulatory of the city of Salvador, were tested for autoantibodies such as antinuclear antibodies, rheumatoid factor, anti-SSA/Ro and anti-SSB/La. Two comparison groups were also included: (a) HTLV-1 patients without KCS and (b) seronegative patients with KCS. Correlation of proviral load (PVL) in HTLV-1 patients with presence or absence of KCS was also assessed. No autoantibodies were detected in HTLV-1 patients with KCS. The PVL of HTLV-1 patients was higher in patients with KCS without other clinical manifestations customarily associated to HTLV-1. In conclusion, in this study, no changes were observed in humoral immunity concerning production of certain autoantibodies in HTLV-1-infected patients with KCS, which suggests that other mechanisms may be involved in the pathogenesis of this manifestation. Additionally, PVL may be a marker of KCS development in these patients.
Literatur
1.
Zurück zum Zitat Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77(12):7415–7419CrossRefPubMed Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77(12):7415–7419CrossRefPubMed
2.
Zurück zum Zitat Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24(39):6058–6068CrossRefPubMed Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24(39):6058–6068CrossRefPubMed
3.
Zurück zum Zitat Galvao-Castro B, Loures L, Rodriques LG et al (1997) Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion 37(2):242–243CrossRefPubMed Galvao-Castro B, Loures L, Rodriques LG et al (1997) Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion 37(2):242–243CrossRefPubMed
4.
Zurück zum Zitat Dourado I, Alcantara LC, Barreto ML, da Gloria Teixeira M, Galvao-Castro B (2003) HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr 34(5):527–531CrossRefPubMed Dourado I, Alcantara LC, Barreto ML, da Gloria Teixeira M, Galvao-Castro B (2003) HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr 34(5):527–531CrossRefPubMed
5.
Zurück zum Zitat Yoshida M, Miyoshi I, Hinuma Y (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79(6):2031–2035CrossRefPubMed Yoshida M, Miyoshi I, Hinuma Y (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79(6):2031–2035CrossRefPubMed
6.
Zurück zum Zitat Gessain A, Barin F, Vernant JC et al (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2(8452):407–410CrossRefPubMed Gessain A, Barin F, Vernant JC et al (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2(8452):407–410CrossRefPubMed
7.
Zurück zum Zitat Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M (1989) Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1(8635):441CrossRefPubMed Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M (1989) Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1(8635):441CrossRefPubMed
8.
Zurück zum Zitat Ijichi S, Matsuda T, Maruyama I, Ijichi S et al (1990) Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. Ann Rheum Dis 49(9):718–721CrossRefPubMed Ijichi S, Matsuda T, Maruyama I, Ijichi S et al (1990) Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. Ann Rheum Dis 49(9):718–721CrossRefPubMed
9.
Zurück zum Zitat Morgan OS, Rodgers-Johnson P, Mora C, Char G (1989) HTLV-1 and polymyositis in Jamaica. Lancet 2(8673):1184–1187CrossRefPubMed Morgan OS, Rodgers-Johnson P, Mora C, Char G (1989) HTLV-1 and polymyositis in Jamaica. Lancet 2(8673):1184–1187CrossRefPubMed
10.
Zurück zum Zitat Eguchi K, Matsuoka N, Ida H et al (1992) Primary Sjogren’s syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 51(6):769–776CrossRefPubMed Eguchi K, Matsuoka N, Ida H et al (1992) Primary Sjogren’s syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 51(6):769–776CrossRefPubMed
11.
Zurück zum Zitat Terada K, Katamine S, Eguchi K et al (1994) Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren’s syndrome. Lancet 344(8930):1116–1119CrossRefPubMed Terada K, Katamine S, Eguchi K et al (1994) Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren’s syndrome. Lancet 344(8930):1116–1119CrossRefPubMed
12.
Zurück zum Zitat Mochizuki M, Watanabe T, Yamaguchi K et al (1992) HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 83(3):236–239PubMed Mochizuki M, Watanabe T, Yamaguchi K et al (1992) HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 83(3):236–239PubMed
13.
Zurück zum Zitat Merle H, Cabre P, Merle S, Gerard M, Smadja D (2001) A description of human T-lymphotropic virus type I-related chronic interstitial keratitis in 20 patients. Am J Ophthalmol 131(3):305–308CrossRefPubMed Merle H, Cabre P, Merle S, Gerard M, Smadja D (2001) A description of human T-lymphotropic virus type I-related chronic interstitial keratitis in 20 patients. Am J Ophthalmol 131(3):305–308CrossRefPubMed
14.
Zurück zum Zitat Buggage RR, Levy-Clarke GA, Smith JA (2001) New corneal findings in human T-cell lymphotrophic virus type 1 infection. Am J Ophthalmol 131(3):309–313CrossRefPubMed Buggage RR, Levy-Clarke GA, Smith JA (2001) New corneal findings in human T-cell lymphotrophic virus type 1 infection. Am J Ophthalmol 131(3):309–313CrossRefPubMed
15.
Zurück zum Zitat Merle H, Smadja D, Le Hoang P, Merle H, Smadja D, Le Hoang P et al (1996) Ocular manifestations in patients with HTLV-I associated infection–a clinical study of 93 cases. Jpn J Ophthalmol 40(2):260–270PubMed Merle H, Smadja D, Le Hoang P, Merle H, Smadja D, Le Hoang P et al (1996) Ocular manifestations in patients with HTLV-I associated infection–a clinical study of 93 cases. Jpn J Ophthalmol 40(2):260–270PubMed
16.
Zurück zum Zitat Merle H, Cabre P, Olindo S, Merle S, Smadja D (2002) Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies). Am J Ophthalmol 134(2):190–195CrossRefPubMed Merle H, Cabre P, Olindo S, Merle S, Smadja D (2002) Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies). Am J Ophthalmol 134(2):190–195CrossRefPubMed
17.
Zurück zum Zitat Nakamura H, Eguchi K, Nakamura T et al (1997) High prevalence of Sjogren’s syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 56(3):167–172CrossRefPubMed Nakamura H, Eguchi K, Nakamura T et al (1997) High prevalence of Sjogren’s syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 56(3):167–172CrossRefPubMed
18.
Zurück zum Zitat Vitali C, Bombardieri S, Moutsopoulos HM et al (1996) Assessment of the European classification criteria for Sjogren’s syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren’s syndrome. Ann Rheum Dis 55(2):116–121CrossRefPubMed Vitali C, Bombardieri S, Moutsopoulos HM et al (1996) Assessment of the European classification criteria for Sjogren’s syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren’s syndrome. Ann Rheum Dis 55(2):116–121CrossRefPubMed
19.
Zurück zum Zitat Dehee A, Cesaire R, Desire N et al (2002) Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods 102(1–2):37–51CrossRefPubMed Dehee A, Cesaire R, Desire N et al (2002) Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods 102(1–2):37–51CrossRefPubMed
20.
Zurück zum Zitat Green JE, Hinrichs SH, Vogel J, Jay G (1989) Exocrinopathy resembling Sjogren’s syndrome in HTLV-1 tax transgenic mice. Nature 341(6237):72–74CrossRefPubMed Green JE, Hinrichs SH, Vogel J, Jay G (1989) Exocrinopathy resembling Sjogren’s syndrome in HTLV-1 tax transgenic mice. Nature 341(6237):72–74CrossRefPubMed
21.
Zurück zum Zitat Hida A, Kawabe Y, Kawakami A et al (1999) HTLV-I associated Sjogren’s syndrome is aetiologically distinct from anti-centromere antibodies positive Sjogren’s syndrome. Ann Rheum Dis 58(5):320–322CrossRefPubMed Hida A, Kawabe Y, Kawakami A et al (1999) HTLV-I associated Sjogren’s syndrome is aetiologically distinct from anti-centromere antibodies positive Sjogren’s syndrome. Ann Rheum Dis 58(5):320–322CrossRefPubMed
22.
Zurück zum Zitat Nakamura H, Kawakami A, Tominaga M et al (2000) Relationship between Sjogren’s syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients. J Lab Clin Med 135(2):139–144CrossRefPubMed Nakamura H, Kawakami A, Tominaga M et al (2000) Relationship between Sjogren’s syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients. J Lab Clin Med 135(2):139–144CrossRefPubMed
23.
Zurück zum Zitat Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sjogren’s disease. J Clin Pathol 21(5):656–660CrossRefPubMed Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sjogren’s disease. J Clin Pathol 21(5):656–660CrossRefPubMed
24.
Zurück zum Zitat Merle H, Cabre P, Smadja D, Josset P, Landau M, Vernant JC (1999) Sicca syndrome and HTLV-I-associated myelopathy/tropical spastic paraparesis. Jpn J Ophthalmol 43(6):509–512CrossRefPubMed Merle H, Cabre P, Smadja D, Josset P, Landau M, Vernant JC (1999) Sicca syndrome and HTLV-I-associated myelopathy/tropical spastic paraparesis. Jpn J Ophthalmol 43(6):509–512CrossRefPubMed
25.
Zurück zum Zitat Pinheiro SR, Lana-Peixoto MA, Proietti AB et al (1995) HTLV-I associated uveitis, myelopathy, rheumatoid arthritis and Sjogren’s syndrome. Arq Neuropsiquiatr 53(4):777–781PubMed Pinheiro SR, Lana-Peixoto MA, Proietti AB et al (1995) HTLV-I associated uveitis, myelopathy, rheumatoid arthritis and Sjogren’s syndrome. Arq Neuropsiquiatr 53(4):777–781PubMed
26.
Zurück zum Zitat Moraes HV Jr, Branco RL, Pinto CMS, Dantas MM, Fiszman R (1995) HTLV-I e Uveíte. Revista Brasileira de Oftalmologia 54(12):39–42 Moraes HV Jr, Branco RL, Pinto CMS, Dantas MM, Fiszman R (1995) HTLV-I e Uveíte. Revista Brasileira de Oftalmologia 54(12):39–42
27.
Zurück zum Zitat Pinheiro SR, Martins-Filho AO, Ribas JG et al (2006) Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1. Am J Ophthalmol 142(5):811–815CrossRefPubMed Pinheiro SR, Martins-Filho AO, Ribas JG et al (2006) Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1. Am J Ophthalmol 142(5):811–815CrossRefPubMed
28.
Zurück zum Zitat Giozza SP, Santos SB, Martinelli M, Porto MA, Muniz AL, Carvalho EM (2008) Salivary and lacrymal gland disorders and HTLV-1 infection. Rev Stomatol Chir Maxillofac 109(3):153–157CrossRefPubMed Giozza SP, Santos SB, Martinelli M, Porto MA, Muniz AL, Carvalho EM (2008) Salivary and lacrymal gland disorders and HTLV-1 infection. Rev Stomatol Chir Maxillofac 109(3):153–157CrossRefPubMed
29.
Zurück zum Zitat Santiago M, Crusoé EQ, Matos AV (2002) Manifestações reumatológicas associadas à infecção pelo HTLV-I. Rev Bras Reumatol 42(5):306–310 Santiago M, Crusoé EQ, Matos AV (2002) Manifestações reumatológicas associadas à infecção pelo HTLV-I. Rev Bras Reumatol 42(5):306–310
30.
Zurück zum Zitat Ono A, Mochizuki M, Yamaguchi K, Miyata N, Watanabe T (1995) Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study. Br J Ophthalmol 79(3):270–276CrossRefPubMed Ono A, Mochizuki M, Yamaguchi K, Miyata N, Watanabe T (1995) Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study. Br J Ophthalmol 79(3):270–276CrossRefPubMed
31.
Zurück zum Zitat Best I, Adaui V, Verdonck K et al (2006) Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru. Clin Exp Immunol 146(2):226–233CrossRefPubMed Best I, Adaui V, Verdonck K et al (2006) Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru. Clin Exp Immunol 146(2):226–233CrossRefPubMed
32.
Zurück zum Zitat Montanheiro PA, Oliveira AC, Posada-Vergara MP et al (2005) Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Braz J Med Biol Res 38(11):1643–1647CrossRefPubMed Montanheiro PA, Oliveira AC, Posada-Vergara MP et al (2005) Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Braz J Med Biol Res 38(11):1643–1647CrossRefPubMed
Metadaten
Titel
Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1
verfasst von
Ana Karina Ferraz-Chaoui
Ajax Mercês Atta
Maria Luiza Sousa Atta
Bernardo Galvão-Castro
Mittermayer B. Santiago
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 6/2010
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1066-5

Weitere Artikel der Ausgabe 6/2010

Rheumatology International 6/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.